天然植物衍生的多糖类向巨细胞两极分化:癌症免疫治疗的有希望的策略
Jingyang Wei1, Yanpeng Dai2, Ni Zhang3
1Second college of clinical medicine, Shandong University of Traditional Chinese Medicine, Jinan, China.
Frontiers in immunology
|October 1, 2024
概括
植物多糖可以调节与瘤相关的巨细胞 (TAMs),将它们转移到抗瘤M1极化状态. 本综述探讨了它们在癌症免疫疗法和临床应用中的潜力.
科学领域:
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
- 在瘤学瘤学.
背景情况:
- 瘤相关巨细胞 (TAMs) 是瘤微环境 (TME) 中的关键免疫细胞.
- TAMs主要以M1 (抗瘤) 和M2 (前瘤) 现型存在,M1极化是癌症免疫治疗的目标.
- 植物多糖具有免疫调节和抗瘤特性,影响免疫系统,特别是巨细胞.
研究的目的:
- 审查植物多糖类对TAMs的监管作用和机制.
- 分析植物多糖类作为免疫辅助剂的潜力,用于癌症治疗中的临床转化.
主要方法:
- 对植物多糖,TAM和癌症免疫治疗研究的文献综述.
- 对多糖类调节巨细胞极化机制的分析.
- 对植物多糖的临床转化机会的评估.
主要成果:
- 植物多糖可以调节TAM极化,有利于抗瘤M1表型.
- 这些多糖体具有显著的免疫调节和抗瘤活性.
- 有证据表明,植物多糖类有可能作为癌症治疗中的免疫辅助剂.
结论:
- 植物多糖为癌症免疫疗法中调节TAM提供了一个有希望的途径.
- 对它们的机制和临床应用的进一步研究可能会导致新的癌症治疗方法.
相关概念视频
Tumor Immunotherapy
489
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
489
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K


